AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
10min chapter
Netflix Adds Over 8 Million Customers, Extends Lead Over Rivals
Bloomberg Businessweek
Novartis's Growth Prospects and Drug Pipeline
This chapter delves into Novartis's drop in ADRs in the U.S. despite a profit forecast raise, emphasizing their strong performance and focus on innovative medicines. Discussions include the progress and optimism around Plavicto, potential FDA approval of Kaskali, expansion plans, and strategies to navigate competition in the pharmaceutical industry. The chapter also highlights the company's long-term vision in creating innovative medicines amidst emerging trends and geopolitical factors.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode